Acceptance & Commitment Therapy for Psychotic Inpatients

Not Applicable

Withdrawn

• Conditions: Acute Psychosis
• Interventions: Behavioral: Attention; Behavioral: Acceptance & Commitment Therapy

• Registration Number: NCT02458105
• Lead Sponsor: Uppsala University

Brief Summary

The overarching aim of the research project is to investigate whether Acceptance \& Commitment Therapy (ACT) is an efficacious psychotherapeutic method of treatment for inpatients suffering from acute psychosis.

The method will be applied in two ways. Firstly, as an individual treatment for patients. Secondly, as an integrated part of the daily work on an inpatient ward, administered by nurses and assistant nurses trained in the method.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-04
• Study First Submitted: 2015-05-27
• Study First Submitted QC: 2015-05-28
• Study First Posted: 2015-05-29
• Primary Completion: 2017-12
• Study Completion: 2017-12
• Status Verified: 2018-05
• Last Update Submitted: 2018-05-04
• Last Update Posted: 2018-05-11

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Admitted to a specified psychiatric inpatient ward during the time-period of the study; psychotic spectrum diagnosis as specified in patient charts; assessed by contact person on the ward as having delusions or hallucinations.

Exclusion Criteria

• Cognitive difficulties to an extent where informed consent cannot be given.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Attention	Attention	Supportive conversation at a frequency and length corresponding to the experimental condition.
Acceptance & Commitment Therapy	Acceptance & Commitment Therapy	A variant of cognitive behavior therapy focused on acceptance and valued living in the presence of distressing symptoms.

Primary Outcome Measures

Name	Time	Method
Rehospitalization	12 months	Whether or not, and if so for how many days, a patient has ben readmitted to inpatient care during the follow-up period.

Secondary Outcome Measures

Name	Time	Method
Clinical Global Impression Scale	12 months	Symptom severity instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
Bull's Eye Values Inventory	12 months	Quality of life instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
Acceptance & Action Questionnaire	12 months	Psychological flexibility instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
EQ-5D	12 months	Health related quality of life instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
Psychotic Symptom Rating Scales	12 months	Symptom severity instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
Checklist of Unit Behaviors	During inpatient care.	Measure for degree of activity on the ward.

Trial Locations

Locations (1)

Västmanland Hospital, Västerås, Västmanland County Council; 🇸🇪 Västerås, Sweden